Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes.
about
The Pain Experience of Hispanic Americans: A Critical Literature Review and Conceptual ModelDevelopment and feasibility of a text messaging and interactive voice response intervention for low-income, diverse adults with type 2 diabetes mellitusBarriers to insulin initiation: the translating research into action for diabetes insulin starts project.Physical activity, obesity, nutritional health and quality of life in low-income Hispanic adults with diabetes.A family-based diabetes intervention for Hispanic adults and their family members.Using quantile regression to investigate racial disparities in medication non-adherence.Correlates of self-care in low-income African American and Latino patients with diabetes.Language barriers, physician-patient language concordance, and glycemic control among insured Latinos with diabetes: the Diabetes Study of Northern California (DISTANCE)Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) studyDiabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.Design of the Lifestyle Improvement through Food and Exercise (LIFE) study: a randomized controlled trial of self-management of type 2 diabetes among African American patients from safety net health centers.Patient-reported racial/ethnic healthcare provider discrimination and medication intensification in the Diabetes Study of Northern California (DISTANCE).Determinants of medication adherence to topical glaucoma therapy.Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011.Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitusDifferences in the clinical recognition of depression in diabetes patients: the Diabetes Study of Northern California (DISTANCE)Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherenceACE inhibitor and ARB medication use among Medicaid enrollees with diabetesRacial differences in medication adherence: A cross-sectional study of Medicare enrollees.Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.Racial disparities in lipid control in patients with diabetes.Nepalese patients' perceptions of treatment modalities for type 2 diabetes.New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.Perspectives and experiences of health care professionals and patients regarding treatments for type 2 diabetes.The association of English ability and glycemic control among Latinos with diabetes.Patient adherence to medication requirements for therapy of type 2 diabetes.Managing diabetes from first diagnosis: choosing well-tolerated therapies with durability.Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice."The More I Do, the Better I'll Be": The Treatment Preferences of Type 2 Diabetes Among African American Men.A Comparison of the Use and Quality of Antidiabetic Medication Regimens Between Non-Hispanic Black and White Adults With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.Pharmacists' perspectives on collaborating with community health workers in diabetes care.Reasons for under-use of prescribed opioid medications by patients in pain.A pharmacist and health promoter team to improve medication adherence among Latinos with diabetes.Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States.
P2860
Q28393437-BB064AA9-906B-44AB-898D-A67E2DF7BC5CQ33439766-5EE5BF06-FD95-40D5-B15E-6E09B0B98ECEQ33751437-2700657A-C2E0-4340-8595-1AD1C6A87F69Q33831145-C9592E04-7896-4AB1-ABBD-45B1395E609DQ33853074-D544F3D5-4725-4A15-B112-921E9250D047Q33924589-A213BC2F-9B9F-4A1F-9BF8-DF45C60C10B5Q34127698-313B6A7B-2989-4626-B9D6-BEDB5F3B1F94Q34482575-1BA492A7-CFE5-4D4B-B41E-6ECECCF5E603Q34507025-59EB35DC-0E3B-4BC9-9283-439117F5D208Q34553412-07DA4B8F-76B8-413D-9AA9-FAE58173D6E3Q34978257-641B81B6-4109-4067-9B62-FB06A7F28485Q35235522-7B2EC144-BF43-44C7-A02B-C3C74BD02156Q35243409-81DB08A2-B102-4BE0-917A-5FEAEFF7F8AFQ36330614-34987577-3534-40EA-8B1C-98A6B3EAC389Q36691780-BB420CE7-1CAA-4885-B490-2EE7BFA3B318Q36990201-65BCE759-AC13-4909-A731-E65BDBAE6C6EQ37007304-14C1C018-D805-47E1-8EBB-7C3654091AC5Q37012091-E43C7FA2-6927-4A07-A331-F9F011701944Q37086603-34205BF3-C6B1-4D7E-8DB8-EA926C9BEF27Q37145955-67E9A77F-3864-4144-9DF4-BBFA9321D5D4Q37154916-EF346C1A-AA06-4D20-882F-CDF9BEBD5A8EQ37265879-994FB16A-F897-4C53-9D71-5CFE0206C56DQ37368835-380EE7FC-061B-4D48-A399-ECF2A326CA86Q37409366-196F495C-717D-4F60-9007-64230881CC3BQ37537092-53754952-4B5E-4388-81F3-430120D56B78Q37662891-D240A684-09C7-4B34-AC5C-E4779E05297DQ37840269-86FC0A43-400C-4F6B-8ECC-69F777E79CD8Q38020015-AAD3937B-8B87-4E20-88D5-99EACCBFFB02Q38815939-6CA89E2A-4184-4E5C-B928-814170C5D8DEQ38858850-FC9C7901-6ED5-4315-A256-A7824FCF5DE8Q40019611-9EA6B60E-C7A3-4923-A69A-9BFEE8C3332DQ40751621-416D95A4-959D-4D34-864B-2D067F0C8F63Q42667768-3CF367EA-9673-454B-B6FF-276C3BBA242DQ43211358-A8E987ED-35C7-470F-B57D-35001D19870AQ55090880-479AC427-A1C0-421A-B116-DEF446CBE822
P2860
Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@en
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@nl
type
label
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@en
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@nl
prefLabel
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@en
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Racial/ethnic differences in c ...... patients with type 2 diabetes.
@en
P2093
Bernard Ewigman
David O Meltzer
Edward Foley
Elbert S Huang
Lisabeth Carlisle
Nidhi Thakur
Sydney E S Brown
P2860
P304
P356
10.2337/DC08-1307
P407
P577
2008-11-18T00:00:00Z